Please login to the form below

Not currently logged in
Email:
Password:

Bayer donation for WFH

Bayer HealthCare has donated $250,000 to the World Federation of Haemophilia, solidifying its continued support of sufferers of blood disorders
Bayer HealthCare has donated $250,000 to the World Federation of Haemophilia (WFH), solidifying its continued support of sufferers of blood disorders.

The company has also given away 950,000 units of its Kogenate treatment to those affected by the disease in the international community, marking World Haemophilia Day on April 17. Events and fund raising activities were organised to increase awareness of blood disorders.

Dr Gunnar Riemann, member of the company's executive committee, said: "Bayer reaffirms its commitment to advance haemophilia care around the world so that patients can enjoy a high quality of life."

"We look forward to continuing our tradition of providing innovative products and services that help people live the lives they choose," he added.

Bayer has donated more than £1m to the WFH over the past four years. It has granted financial assistance totalling $13m to researchers and caregivers through the Bayer Haemophilia Awards Program (BHAP) since its inception six years ago. In 2007, Bayer gave away a large amount Kogenate to China, helping to avert a humanitarian crisis.

Mark Skinner, president of the WFH, said: "With Bayer as a committed partner to the haemophilia community, we can make great progress in achieving our common vision of 'treatment for all'."

17th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics